Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

Healthcare Biotechnology
BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by frankmanon Dec 23, 2024 4:27pm

Last 2 trades other market .07

Time ET Ex Price Change Volume Buyer Seller 15:43:02 O 0.07 0.005 15,000 80 National Bank  ...more  
27
Post by frankmanon Dec 23, 2024 3:20pm

Damn asks are at .07 L2 bid ask

0.08 37,000 5 0.075 15,761 5 0.07 215,000 6 Bid 0.065 46,000 1 0 ...more  
31
Post by frankmanon Dec 23, 2024 2:15pm

Here is the level 2 depth by order

Bid   Ask Broker Size Price   Price Size Broker 80 National Bank 1,000 0.06  ...more  
38
Post by frankmanon Dec 23, 2024 2:07pm

I see my end of year bid for trading shares

A few days left for tax loss season. If I don’t get them that’s ok I will try again if I get the chance. Still going to be a happy new year in 2025. End of message.
30
Comment by javaman12on Dec 21, 2024 10:56pm

RE:RE:Asks were at .07 at close Last trades at close CDN

The DPX lipid delivery platform doesn't necessarily need to have a complicated onboard biomolecular cargo to stimulate a strong immune response. It just the needs the addition of a check point ...more  
31
Discussion
Comment by javaman12on Dec 21, 2024 2:48pm

RE:Asks were at .07 at close Last trades at close CDN

It's good to see the share price moving again in the right direction! Recently, there has been a huge volume in the buying of BioVaxys shares. Hopefully, the share price will soon gain some ...more  
40
Discussion
Post by frankmanon Dec 20, 2024 4:05pm

Asks were at .07 at close Last trades at close CDN

Time ET Ex Price Change Volume Buyer Seller 15:59:15 C 0.065 0.005 1,000 1 Anonymous ...more  
52
Discussion
Post by frankmanon Dec 20, 2024 3:53pm

2.3 mil shares traded 1 mil $US OTC .065

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS 13.0 0.06 · 0.065 29.0 0 ...more  
36
Post by frankmanon Dec 20, 2024 12:24pm

1.7 mil shares traded (1/2 day) / $US OTC BVAXF 800k~ .065

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr ATS 43.0 0.06 · 0.065 404.5 0 ...more  
49
Comment by frankmanon Dec 20, 2024 11:27am

RE:RE:I still expect 50 to 100 percent increase in stock rice

Hideaway absolutely agree. In the early days though they did have temporary corroboration with Merck. They only had two vaccines then. With DPX the products are almost endless. And they do have ...more  
47
Discussion
Post by johnfever21on Dec 20, 2024 10:38am

BIOVAXYS ANNOUNCES CLOSING OF SECOND TRANCHE OF PRIVATE PLAC

VANCOUVER, BC, Dec. 18, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce that it has closed the second ...more  
35
Comment by Hideawayon Dec 20, 2024 10:30am

RE:I still expect 50 to 100 percent increase in stock rice

Frankman,I hope you are proven correct but I'm hesitant to increase my position.Passins last newsletter gave a great picture as to the potential for Biov but getting pharma onboard will be no easy ...more  
29
Discussion
Comment by frankmanon Dec 19, 2024 3:54pm

RE:RE:BIOV Potential

Thank you Working Link
9
Discussion
Post by frankmanon Dec 19, 2024 3:33pm

I still expect 50 to 100 percent increase in stock rice

Into March 2025  as I said before. a good doublte to start. End of message.
47
Discussion
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities